Systemic Type I Interferon Blockade Mitigates Insulin Resistance in a Preclinical Model of Psoriasis
{{output}}
Psoriasis is a cutaneous autoimmune disease with worldwide prevalence. In situ activation of skin-infiltrating plasmacytoid dendritic cells (pDCs) leading to local induction of type I interferons (IFNs) is a crucial innate initiation event in psoriasis. Psoria... ...
